Avastin® (bevacizumab) Plus IFN in mRCC

Dr Ronald Bukowski, Professor Emeritus at Cleveland Clinic’s Taussig Cancer Institute, and Dr Thomas Hutson, genitourinary medical oncologist at Baylor University Medical Center, present this educational and interactive guide reviewing metastatic renal cell carcinoma (mRCC). This iPub presentation has been designed to address important issues of clinical significance for physicians treating metastatic kidney cancer.

This interactive guide was designed to provide informative and invaluable data that helps physicians provide the most effective evidence-based care possible for their patients. The clinical topics of this interactive publication delve deeper into the use of bevacizumab plus interferon alfa for patients with metastatic renal cell carcinoma.

View more interactive publications